ABSTRACT
INTRODUCTION
T2DM is believed to be a multifactorial disease, it is influenced by both genetic and environmental factors such as increased calorie intake (1) . People with family history of the disease are at higher risk of developing T2DM since they share genetic background and likely share similar environments. Therefore, genetic factors were considered key determinants of the individual susceptibility to T2DM; it has been estimated that 30-70% of T2DM risk can be attributed to genetic factors (1) . Interleukin 4 (IL-4) was originally discovered as a low molecular weight T cell-derived polypeptide of 129 amino acids, which is encoded by the IL-4 gene on chromosome 5q23.31. It is secreted by helper T cells (CD4) type 2 (Th2) lymphocytes, and natural killer (NK) T cells, and by cells of the innate immune system, including mast cells, basophils, and esinophils (2) . Interleukin 4 regulates proliferation, apoptosis, gene expression, and differentiation in many hematopoietic cells; in particular, it directs the immunoglobulin (Ig) class switch to IgG1 and IgE, and down-regulates the production of Th1 cells (3,4) . Interleukin 13 is a 12 kDa protein product, produced by Th2 cells, and genetically implicated in the pathogenesis of inflammatory and immune systemic diseases, such as asthma and atopy. IL-13 shares several biological profiles with IL-4 including IgE production, CD23 and MHC class II expression, inhibition of antibody-dependent cell-mediated cytotoxicity with downregulation of IgG type I receptor and suppression of type I interferon (5) . Investigators of that field believe that T2DM is associated with immune system and in turn is related to the alteration of Th2 to Th1 immune response patterns (6) . It was reported that cytokine imbalance is involved in the pathogenesis of T2DM (7) . In addition, polymorphisms in the IL4R, IL-4, and the IL-13 loci have been reported to be associated with immune disorders and serum immunoglobulin levels (8) .
The aim of the present work is to investigate the relationship of polymorphisms of IL-13-1112 C>T and IL-4-590 C>T genes to the susceptibility and severity of type 2 DM among Egyptian patients from the Nile Delta region of Egypt. For all participants, DNA was isolated from whole blood according to the Generation DNA Purification Capture Column kit supplied by Fermentas, #K0721, USA.
SUBJECTS & METHODS

Genotyping of IL-4-590 C>T:
For detection of the IL-4 gene polymorphism -590 C>T (rs2243250), the allele-specific PCR method (ARMS-PCR) was performed as described by Howell et al. (12) . In brief, for each person, two reactions were carried out with each of the forward primers: T primer: 5′-CTA AACTTGGGAGAACATTGTT-3′ or IL-4 F C primer: 5′-CTAAACTTGGGAGAACATTGTC-3′ Each of the two reactions contained the reverse primer IL-4 5′-AGTACAGGTGGCATCTTGGAAA-3′ (12) . Reactions contained 5 µl of each primer, 10 µl of Dream Taq Green PCR Master Mix (2X) (Fermentas, K 1081, USA) to a final volume of 25 µl, amplification was performed on thermal cycler with 1 min at 96°C, followed by 10 cycles of 96° C for 15 s, 1 st 10 cycle at 65.5° C for each SNP for 50 s, 72° C for 40 s; then 20 cycles of 96° C for 10 s, 60° C for 50 s, 72° C for 40 s. PCR products were loaded directly onto 2% agarose gels (containing 0.5 µg/ml ethidium bromide), electrophoresed and visualized by photography under UV transillumination.
Genotyping of IL-13-1112 C>T:
For detection of the IL-13 gene polymorphism -1112C>T (rs1800925), the allele-specific PCR method (ARMS-PCR) was performed as described by Hummelshoj et al., (13) In brief, for each person, two reactions were carried out with each of the forward primers: IL-13 -1046F C primer:
5′-TTCTGGAGGACTTCTAGGAAAA C-3′ or IL-13 -1046F T primer: 5′-TTCTGGAGGACTTCTAGGAAAA T-3′. Each of the two reactions contained the reverse primer IL-13 -740R:
5′-GGAGATGGGGTCTCACTATG-3′
(13) .
Reactions contained 5µl of each primer, 12 µl Dream Taq DNA Master Mix (2X, Fermentas, K1081, USA), to a final volume of 25 µl amplification was performed on thermal cycler with 2 min at 94°C, 15 cycles of 30 s at 94°C, 60 s at 63°C and 60 s at 72°C, 20 cycles of 30 s at 94°C, 60 s at 60°C and 60 s at 72°C, and finally 5 minutes at 72°C. The PCR products were separated on 2% agarose gel, band appears at 400 bp.
Statistical analysis:
Data were processed and analyzed using the Statistical Package of Social Science (SPSS, version 17). The frequency of studied allelic polymorphism among patients was compared to that of controls describing number and percent of each and tested for positive association using Fisher exact test and odds ratio (OR) with 95% confidence intervals (CI). A minimum level of P < 0.05 is considered significant. There was a significant increase in fasting insulin level in patients with CC genotype of IL-13 compared to those with CT and TT genotypes (87.5 ± 79.2 vs. 57.3 ± 43.1 and 49.9 ± 54.8 IU/ml respectively; p= 0.008). Also, there was a significant increase in fasting insulin level in patients with CT genotype compared to those with CC and TT genotypes (57.3 ± 43.1 vs. 87.5 ± 79.2 and 49.9 ± 54.8 IU/ml respectively; p = 0.02). On the other hand there was no statistically significant differences regarding genotypes of IL-4-590 CT, p>0.05 (table 3) .
RESULTS
Fasting blood sugar at presentation was significantly lower in patients with CC genotype of IL-13-1112 compared to those of CT and TT genotype (159.7± 63.9 Vs. 201.1 ± 76.9 and 207.50 ± 74.1 mg/dl respectively; p=0.01). Also, FBS was significantly lower in patients with CT genotype compared to other genotypes, (201.1 ± 76.9 versus 159.7± 63.9 and 49.9 ± 54.8 mg/dl respectively; p= 0.02) (table 3) . Regarding insulin resistance, HOMA level, in IL-13-1112 was 32.4±29.5 in CC genotype patients, with marked insulin resistance versus 27.7±25 in CT genotype and 20.2 ± 17.6 in TT genotype which showed less insulin resistance, but these figures did not reach statistical significance (p>0.05) (table 3). Patients of IL-4-590 CC genotype also, was higher in insulin resistance than patients of CT and TT genotypes (36.2±37, 27.7±24, 23.70 ± 30.4 respectively), also still statistically insignificant (p>0.05) (table 3) . No statistically significant difference was noted comparing the frequencies of IL-13-1112 C/T and IL-4-590 C/T genotypes when comparing patient subgroups as regard HBA 1c , p> 0.05 (table 3) . CT genotype of IL-13-1112 showed lower frequency of patients with retinopathy compared to CC and TT genotype (33.3 versus 78.3%) (data not shown). 
DISCUSSION
Immune system plays key roles in the pathogenesis of type 2 diabetes (7) . Cytokines are key mediators which regulate immune response and it is well established that expression of cytokines by immune cells depends on several factors such as infection, inflammation, hormonal condition and also cytokines gene polymorphisms (14) . IL-4 and IL-13 located to a region on chromosome 5q31-q33, this region contains a cluster of proinflammatory cytokines important in immune regulation. IL-4 and IL-13 share a receptor component, IL-4Rα, which has been shown to be an important factor in the development or expression of atopy and asthma (8) . The present study showed that type 2 diabetes mellitus is associated with certain polymorphic genotypes pertaining to Il-4-590 CT and IL-13-1112 CT genes. Homozygosity CC of IL-4-590 gene showed significantly lower frequency in patients when compared to the control group. Heterozygosity CT of IL-4-590 gene showed significantly higher frequency in patients compared to control group. In addition, insulin levels and blood glucose varied in accordance with patients genotypes. So, there was a significant increase in fasting insulin level in patients with CC genotype of IL-13 compared to those with CT and TT genotypes, fasting blood sugar at presentation was significantly lower in patients with CC genotype of IL-13-1112 compared to those of CT and TT genotype.
Regarding IL-13-1112 C>T genetic polymorphisms, to our knowledge, this is the first report studying the relation between IL-13-1112 (C>T) polymorphism and T2DM. Our results showed a highly significant increase in IL-13 CT genotype in diabetic cases when compared to control group. There is no significant difference in IL-13-1112 allelic frequencies between the diabetic and control group. On the other hand, IL-13-1112 (CC+ TT) was higher in control non-diabetic group versus type 2 diabetic group. For other immune disorders these findings go in hand with the finding of Cui et al., (20) who reported that IL-13-1112 C/T polymorphisms were significantly associated with asthma. Kim et al., (2003) (21) found that two IL-13 promoter polymorphisms A-1512C and C-1112T were significantly associated with total IgE levels in Korean children with asthma. These results are in contrast to result of Maier et al.
(17) who concluded that IL-13 variants are not associated with type 1 diabetes in British patients.
Taking into consideration the fact that genetic polymorphisms are population specific, we can come to the conclusion that IL-4-590 CT and IL-13-1112 CT gene polymorphisms are associated with type 2 DM among Egyptian population. In this respect, we recommend further larger studies in multiplex families. 
